GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 with or without Anosmia Genetic Test
Welcome to DNA Labs UAE, where we offer the GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 with or without Anosmia Genetic Test. This test helps in diagnosing and managing the condition caused by mutations in the GNRH1 gene.
Test Details
The GNRH1 gene is responsible for encoding the gonadotropin-releasing hormone (GnRH), which plays a crucial role in regulating reproductive function. Hypogonadotropic hypogonadism type 12 (HH12) is a specific type of hypogonadotropic hypogonadism caused by mutations in the GNRH1 gene.
Hypogonadotropic hypogonadism is a condition characterized by a deficiency in the production or release of gonadotropin hormones (FSH and LH) from the pituitary gland. This leads to impaired sexual development and reduced fertility. In HH12, individuals may present with or without anosmia, which is the inability to perceive odors and is a common symptom in some forms of hypogonadotropic hypogonadism.
Test Components and Price
Our GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 with or without Anosmia Genetic Test is priced at 4400.0 AED. The test can be conducted using blood, extracted DNA, or one drop of blood on an FTA card as the sample condition.
Report Delivery and Method
The report for the GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 with or without Anosmia Genetic Test is delivered within 3 to 4 weeks. The test is performed using NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes to identify potential mutations or variations associated with the condition.
Test Type and Referring Doctor
The GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 with or without Anosmia Genetic Test falls under the Hepatology, Nephrology, and Endocrinology Disorders test types. The referring doctor for this test is a General Physician.
Test Department and Pre-Test Information
This genetic test is conducted in our Genetics department. Before undergoing the GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 with or without Anosmia Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the condition.
Understanding NGS Genetic Testing for HH12
NGS genetic testing is a powerful method used to analyze multiple genes simultaneously to identify potential mutations or variations associated with specific conditions. In the case of HH12, NGS genetic testing helps identify mutations in the GNRH1 gene responsible for the individual’s symptoms.
By pinpointing the specific genetic mutation causing HH12, NGS genetic testing confirms the diagnosis, provides information about the inheritance pattern, and guides appropriate management and treatment options for affected individuals and their families.
At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Our GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 with or without Anosmia Genetic Test can assist in the diagnosis and management of this condition. Contact us today to schedule an appointment or learn more about our services.
| Test Name | GNRH1 Gene Hypogonadotropic hypogonadism type 12 with or without anosmia Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GNRH1 Gene Hypogonadotropic hypogonadism type 12 with or without anosmia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GNRH1 Gene Hypogonadotropic hypogonadism type 12 with or without anosmia NGS Genetic DNA Test gene GNRH1 |
| Test Details |
The GNRH1 gene is responsible for encoding the gonadotropin-releasing hormone (GnRH), which is essential for the regulation of reproductive function. Hypogonadotropic hypogonadism type 12 (HH12) refers to a specific type of hypogonadotropic hypogonadism (HH) caused by mutations in the GNRH1 gene. Hypogonadotropic hypogonadism is a condition characterized by a deficiency in the production or release of gonadotropin hormones (FSH and LH) from the pituitary gland, leading to impaired sexual development and reduced fertility. In HH12, individuals may present with or without anosmia (the inability to perceive odors), which is a common symptom in some forms of HH. NGS (Next-Generation Sequencing) genetic testing refers to a method used to analyze multiple genes simultaneously to identify potential mutations or variations that may be associated with a particular condition. In the case of HH12, NGS genetic testing can be performed to identify mutations in the GNRH1 gene that may be responsible for the individual’s symptoms. By identifying the specific genetic mutation causing HH12, NGS genetic testing can help confirm the diagnosis, provide information about the inheritance pattern, and guide appropriate management and treatment options for affected individuals and their families. |
